Team | Fusion Genomics Corp.

Mohammad Qadir, President & Chief Scientific Officer

Dr Qadir’s training is in genetics and molecular biology. Dr Qadir has over 17 years of research experience. The last ten were at the British Columbia Cancer Agency where he worked with world-renowned experts in genomics and drug development. Dr Qadir is the co-inventor of the CHILDSeq-Sarcoma assay and CHILDDecode (part of FUSIONCloud™). Dr Qadir oversees all the scientific aspects of research and development efforts at FUSION GENOMICS and also serves as the interface for all collaborators.

Greg Stazyk, Chief Technical Officer

Mr Greg Stazyk has over 20 years of experience in senior positions in the IT industry, including senior manager at PMC-Sierra Inc. where he was responsible for its global computer systems operation. Mr. Stazyk was the IT lead for one of Canada’s largest bioinformatics computing platforms at the BC Cancer Agency’s Genome Sciences Centre. Here, he oversaw the expansion of their computing infrastructure from a few dozen core-machines to over 10,000 in the core cluster and over 7 Petabyte of redundant storage in a CAP/CLIA certified environment. Mr Stazyk brings insight and expertise in IT project management, especially in areas of business fault tolerance and secure storage systems, which are critical for fulfilling FUSION GENOMICS’ cloud computing needs.

Akmal Jameel, Chief Financial Officer

Mr Jameel has over 25 years of experience in transaction support, PE & VC investments and fund raising. He has participated in over US$ 1 billion of transactions and has Board-level experience on a number of companies. Mr Jameel has advised startups in the fields of media, technology and logistics. He is a CFA charter holder and holds a Masters degree in accounting and finance from the London School of Economics and Political Sciences.

Shing Zhan, Senior Director Bioinformatics

Dr Shing Hei Zhan completed his PhD (direct entry) at the University of British Columbia as a CIHR Banting and Best Doctoral Research Awardee with Prof. Sarah Otto, a MacArthur Fellow and a member of the National Academy of Sciences of the USA. He has published 22 peer-reviewed articles on a broad range of topics – evolutionary biology and ecology, microbiology, laboratory medicine, bioinformatics, and genomics – in reputed journals, such as Science and Nature. He has been overseeing the development of bioinformatics methodologies at Fusion Genomics Corp. since the founding of the company.

Brian Kwok, VP of Product Development

Mr Kwok is a graduate of the molecular biology and biochemistry program at Simon Fraser University and trained at the BC Cancer Agency’s Genome Sciences Centre. Mr.Kwok has 10 years of experience in molecular biology and genomic technologies including leading edge Next Generation Sequencing (NGS). Mr. Kwok worked at the Koninklijk Instituut voor de Tropen (KIT), also known as The Royal Tropical Institute in the Netherlands, where he was actively involved in developing molecular diagnostic assays for the identification of drug-resistant tuberculosis. Mr. Kwok has worked in combinatorial drug screening and led the development of the CHILDSeq-Sarcoma assay. He is responsible for the development, testing, and production of FUSION’s new assays

Rich Sobel, Director of Communications

Dr Sobel has over 20 years experience in research, grant writing and development, communication and project management. Rich spent seven years in prostate cancer research as an Associate Scientist at the BC Cancer Agency and the Genome Sciences Centre (GSC). He left the “bench” to work as a research project manager and grant facilitator. As a former Research Development Facilitator at BC’s Child & Family Research Institute, he helped bring in $20 million dollars of peer-reviewed research funding each year for institute investigators.